Listing Rules and Guidance: Contents


 
 

The HKEX Rules, Interpretation and Guidance are maintained by Thomson Reuters Governance, Risk and Compliance to organise the materials for greater accessibility. Hyperlinked cross references are now available in the HTML versions.

In the case of discrepancies between HTML and PDF versions of the HKEX Rules, Interpretation and Guidance, the PDF version prevails.

  Versions
(1 version)
 
Apr 24 2018 onwards

Update No. 119

Note to subscribers for the amendments to the rules governing the listing of securities (the "Listing Rules")

Update No. 119

April 2018

Dear Sirs,

Amendments to the Main Board Listing Rules

We enclose reprinted pages of the Listing Rules and filing instructions. The reprinted pages incorporate amendments to implement the proposals of the "Consultation Conclusions Paper on a Listing Regime for Companies from Emerging and Innovative Sectors" published on 24 April 2018.

We have amended the Listing Rules to:

•   permit listings of Biotech Companies that do not meet any of the Main Board financial eligibility tests;
•   permit listings of companies with weighted voting right structures; and
•   establish a new concessionary secondary listing route for Greater China and international companies that wish to secondary list in Hong Kong.

Coming into effect

The amendment will come into effect on 30 April 2018.

Please click HERE to see the amendments to the Listing Rules.

Yours faithfully,
For and on behalf of

The Stock Exchange of Hong Kong Limited
David Graham

Chief Regulatory Officer and Head of Listing